Home › Parkinson's Disease › New York
Parkinson's Disease clinical trials in New York
32 studies for Parkinson's Disease are looking for participants at sites in New York.
Cities in New York
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Northwell Health Neuroscience Institute, Great Neck
- University at Buffalo, Williamsville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Dent Neurological Institute, Amherst
- Parkinson's Research Centers of America - Long Island, Commack
- Weill Cornell Medical College, New York
- and 1 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT07174310Parkinson's Disease in Type 1 Gaucher Disease
- Icahn School of Medicine at Mount Sinai, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 5, 2026 · NCT07886879A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- UBMD Neurology, Buffalo
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Nov 2, 2026 · NCT06944522A Study of Buntanetap in Participants With PD
- Mount Sinai Hospital, New York
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Oct 30, 2026 · NCT07284784A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Northwell Health, Manhasset
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
- and 1 more
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 30, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Oct 28, 2026 · NCT07432958A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-006, Albany
- Site-005, New York
RecruitingPhase 2/3
Ages 40 to 80 · All sexes · Updated Oct 22, 2026 · NCT06976268A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- New York Presbyterian Hospital-Columbia University Medical Center, New York
RecruitingPhase 1/2
Ages 40 to 72 · All sexes · Updated Oct 21, 2026 · NCT06753331Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Recruiting
Ages 50 and older · All sexes · Updated Oct 15, 2026 · NCT06993142Rehabilitation of Airway Protection in Parkinson's Disease
- Teachers College, Columbia University, New York
RecruitingPhase 2
Ages 50 to 90 · All sexes · Updated Oct 8, 2026 · NCT05700825Visual Hallucinations in Lewy Body Diseases
- NYU Langone Health, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Sep 30, 2026 · NCT07849413GBPDC: Gut-Brain in PD Consortium Master Protocol
- Columbia University, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 21 to 80 · All sexes · Updated Sep 25, 2026 · NCT07567794Speech Learning and Speech Production in Parkinson's Disease
- State University of New York at Buffalo, Buffalo
Recruiting
Ages 45 and older · All sexes · Updated Sep 22, 2026 · NCT07403539Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Weill Cornell Medical College, New York
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 21, 2026 · NCT07005180Parkinson's Foundation PD GENEration Genetic Registry
- Mount Sinai, New York
- Columbia University, New York
- University of Rochester Medical Center, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Northwell Health, New York
- Stony Brook University, Stony Brook
- University of Buffalo Jacobs School of Medicine, Williamsville
RecruitingObservational study
Ages 45 to 75 · All sexes · Updated Sep 4, 2026 · NCT07330258Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
- NYU Langone Health, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07752355Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 55 to 90 · All sexes · Updated Aug 4, 2026 · NCT04239079Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Radial Midtown Manhattan, New York
Recruiting
Ages 22 to 80 · All sexes · Updated Jul 31, 2026 · NCT07207122PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
- University of Rochester, Rochester
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
- New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center, Old Westbury
Recruiting
All ages · All sexes · Updated Jun 29, 2026 · NCT06671600Natural History Study of Synucleinopathies
- NYU Medical Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT01799915Parkinson's Disease Biomarkers in Nerve Cells in the Gut
- Weill Cornell Medicine, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated May 22, 2026 · NCT05347407This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
- Cornell University Weill Medical College, New York
RecruitingPhase 1/2
Ages 30 to 75 · All sexes · Updated May 11, 2026 · NCT07102342A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Weill Cornell Medicine, New York
RecruitingObservational study
Ages 30 to 99 · All sexes · Updated Mar 20, 2026 · NCT05539196Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Albany Medical Center, Albany
RecruitingObservational study
All ages · All sexes · Updated Jan 8, 2026 · NCT04071847Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Parkinson's Disease and Movement Disorders Center - Long Island, Commack
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 22, 2025 · NCT07219927A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Parkinson's Research Centers of America - Long Island, Commack
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 24, 2025 · NCT06765668NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
RecruitingObservational study
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
- Teachers College, Columbia University, New York
RecruitingEarly phase 1
Ages 50 to 80 · All sexes · Updated Aug 15, 2024 · NCT06540989From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.